Background: Cigarette smoking is a risk factor for cardiovascular disease (CVD) and has both beneficial and harmful effects in CVD. We hypothesized that weight gain following smoking cessation does not attenuate the CVD mortality of smoking cessation in the general Korean population. Methods: Study subjects comprised 2.2% randomly selected patients from the Korean National Health Insurance Corporation, between 2002 and 2013. We identified 61,055 subjects who were classified as current smokers in [2003][2004]. After excluding 21,956 subjects for missing data, we studied 30,004 subjects. We divided the 9,095 exsmokers into two groups: those who gained over 2 kg (2,714), and those who did not gain over 2 kg (6,381, including weight loss), after smoking cessation. Cox proportional hazards regression models were used to estimate the association between weight gain following smoking cessation and CVD mortality. Results: In the primary analysis, the hazard ratios of all-cause deaths and CVD deaths were assessed in the three groups. The CVD risk factors and Charlson comorbidity index adjusted hazard ratios (aHRs) for CVD deaths were 0.80 (95% confidence interval [CI], 0.37 to 1.75) for ex-smokers with weight gain and 0.80 (95% CI, 0.50 to 1.27) for ex-smokers with no weight gain, compared to one for sustained smokers. The associations were stronger for events other than mortality. The aHRs for CVD events were 0.69 (95% CI, 0.54 to 0.88) and 0.81 (95% CI, 0.70 to 0.94) for the ex-smokers with and without weight gain, respectively. Conclusion: Although smoking cessation leads to weight gain, it does not increase the risk of CVD death.
INTROduCTION
Cigarette smoking is not only associated with cancer, but is also one of the best-known modifiable risk factors for cardiovascular disease (CVD). 1, 2) Cigarette smoking affects endothelium-dependent vasodilatation; therefore, it mediates inflammation, dyslipidemia, platelet dysfunction, and coagulation problems. Additionally, smoking increases the incidences of hypertension and diabetes. 3, 4) Smoking cessation reduces CVD risk; 5) however, weight gain following smoking cessation is one of the reasons people either do not try to quit or relapse following smoking cessation. 6, 7) In addition, weight gain itself is a risk factor for CVD. 8) Vascular mortality increases 40% for every five-unit increase in body mass index (BMI) above 25. 9) The mean weight gain after smoking cessation varies between 3 and 6 kg in North America and Asia. This weight gain generally occurs within six months after smoking cessation, and it persists over time. 6, [10] [11] [12] [13] [14] Therefore, there is some concern that weight gain after smoking cessation might attenuate the CVD-related benefits of quitting smoking.
Few previous studies have examined the association between weight gain after smoking cessation and CVD. Some of these have
shown that smoking cessation is associated with a lower risk of CVD, 10, 11, 15) despite weight gain; however, these studies have some limitations. First, most of them were conducted in the West, 10, 15) and there are very few studies regarding this issue in Asia. Second, all these studies assessed the effects of weight gain following smoking cessation on CVD indirectly. For example, one study calculated changes in estimated CVD incidence risk following weight gain using BMI, systolic blood pressure (SBP), and total cholesterol, instead of the actual incidence count itself. 11) Another study analyzed the associations between weight gain after smoking cessation and CVD by comparing hazard ratio differences between weight changes. This included adjusted hazard ratios (aHRs) and only adjusted for CVD risk factors. 10) Therefore, the aim of this study was to assess the associations between weight gain following smoking cessation and CVD mortality directly. We hypothesized that smoking cessation would decrease CVD mortality risk compared to continued smoking, despite the associated weight gain.
mEThOdS

Screening program in Korea
In South Korea, there is universal healthcare coverage, the Korean Na- 
data Collection
The 
participants
We used data from all KNHI members who underwent a screening ex- All participants were classified as current smokers, ex-smokers, or non-smokers based on self-reported questionnaires completed at each examination.
We excluded participants with CVD diagnosed before 2007. In our study, CVD was defined as coronary heart disease (CHD) and stroke. smoking. We divided the ex-smokers into two groups: those who gained over 2 kg after smoking cessation, and those who did not gain over 2 kg (some of them even lost weight). The latter group was named the no weight gain group ( Figure 1 ). The cutoff point for weight gain of over 2 kg was determined based on previous studies, since 2 kg is the typical weight gain following smoking cessation in Asia. 11, 20) However, weight gain of over 5 kg might increase the risk of CVD mortality.
Study Outcomes
The primary outcome for this study was CVD mortality. We defined CVD as a composite of CHD, including myocardial infarction (ICD-10 codes I21-I22) and stroke (ischemic and hemorrhagic stroke, I60-I64).
The secondary outcomes were all-cause mortality and CVD events.
Vital status was assured routinely by matching KNHI data with the National Death Registry. CVD deaths were defined as deaths with underlying ICD-10 codes I00-I99, as registered in the National Death Registry. 
Statistical analysis
RESuLTS
Of the 39,099 study participants, 30,004 were still smoking, and 9,095 Values are presented as number (%) or mean±standard deviation. *Calculated as weight in kilograms divided by height in meters squared. (Table 2) . Only the CVD risk factors and Charlson comorbidity index aHRs for stroke mortality were higher among ex-smokers who gained weight, but the 95% CI was too wide to confirm due to the small numbers of casualties.
During follow-up, 1,343 CVD events occurred. We analyzed HRs for the CVD events to evaluate the associations between weight gain following smoking cessation and CVD risk. The associations were stronger with events other than mortality. The CVD risk factors and Charlson comorbidity index aHRs for the CVD events were 0.69 (95% CI, 0.54 to 0.88) and 0.81 (95% CI, 0.70 to 0.94) for the ex-smokers who gained weight and those who did not, respectively ( Table 3) .
As previously mentioned, weight gain of over 5 kg might increase CVD mortality and all-cause mortality risk compared to sustained smokers. The CVD risk factors and Charlson comorbidity index aHRs for all causes death were 1.21 (95% CI, 0.77 to 1.90) and 0.85 (95% CI, 0.73 to 0.99) for ex-smokers who gained weight and those who did not, respectively, although the differences were not statistically significant (Appendix 1). As for CVD events, the results were not markedly different from the 2 kg cutoff for weight gain (Appendix 2).
dISCuSSION
In our study, we used the NSC (2002-2013) database to assess the associations between weight gain after smoking cessation and CVD mortality. Therefore, our study represents the general Korean population. We found that ex-smokers tended to have lower CVD mortality risk. Furthermore, there was less death risk from all causes despite weight gain following smoking cessation. In addition, ex-smokers had significantly lower risks of CVD events compared to sustained smokers, despite weight gain.
One community-based cohort study of the associations between weight gain following smoking cessation and CVD conducted in the United States found that there was an association between smoking cessation and lower CVD risk that was not modified by weight gain.
The aHR for CVD risk factors and weight change was 0.61 (95% CI, 0.21 to 1.78) for ≤4 years quitters, 0.29 (95% CI, 0.16 to 0.52) for >4 years quitters (for smokers, this value was 1). 10) A similar study was conducted in Japan in 2010. Among the male working population, weight gain after smoking cessation was approximately 2 kg, and the estimated CHD risk four years later was 0.76 (95% CI, 0.68 to 0.85), compared to sustained smokers.
11)
However, these studies were not without limitations. They did not assess the effects of weight gain following smoking cessation in association with CVD events or mortality itself. Instead, they assessed the effect through weight gain aHR or estimated CVD risk. In addition, the study conducted in Japan included only Japanese male workers; therefore, they were unable to apply the results to the general population.
The offspring cohort of the Framingham Heart Study had as long as a follow-up period as presented here; however, these participants were mainly Caucasians. 
